UK markets closed

Theralase Technologies Inc (TTX.DU)

Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Add to watchlist
0.0995-0.0035 (-3.40%)
At close: 07:32PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-4,571
-4,571
-5,235
-4,411
-5,599
Depreciation & amortisation
286.124
286.124
313.231
276.15
272.279
Stock-based compensation
621.241
621.241
191.666
318.354
912.032
Change in working capital
-435.717
-435.717
-421.89
-237.916
-49.643
Accounts receivable
-25.28
-25.28
-31.186
229.189
389.356
Inventory
-172.65
-172.65
80.651
-113.948
270.32
Other working capital
-4,110
-4,110
-5,173
-4,131
-4,611
Other non-cash items
30.406
30.406
21.249
5.342
9.68
Net cash provided by operating activities
-4,073
-4,073
-5,103
-4,030
-4,446
Cash flows from investing activities
Investments in property, plant and equipment
-37.265
-37.265
-70.412
-100.824
-164.576
Net cash used for investing activities
-37.265
-37.265
-70.412
-100.824
-164.576
Cash flows from financing activities
Debt repayment
-117.148
-117.148
-75.748
-56.619
-52.279
Common stock issued
2,763
2,763
2,722
0
0
Other financing activities
-1,597
-0.75
-0.75
-0.75
-5.461
Net cash used provided by (used for) financing activities
2,645
2,645
2,990
-57.369
-57.565
Net change in cash
-1,465
-1,465
-2,183
-4,189
-4,668
Cash at beginning of period
1,509
1,509
3,692
7,880
12,549
Cash at end of period
43.911
43.911
1,509
3,692
7,880
Free cash flow
Operating cash flow
-4,073
-4,073
-5,103
-4,030
-4,446
Capital expenditure
-37.265
-37.265
-70.412
-100.824
-164.576
Free cash flow
-4,110
-4,110
-5,173
-4,131
-4,611